Moderna Inc (MRNA) financials · rev $1.94B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Moderna Inc (MRNA) rev $1.94B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.94B | $3.24B |
| Cost of Revenue | $868.0M | $1.46B |
| Gross Profit | $1.08B | $1.77B |
| Operating Income | -$3.07B | -$3.94B |
| Net Income | -$2.82B | -$3.56B |
| EPS (Diluted) | -$7.26 | -$9.28 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $12.34B | $14.14B |
| Current Assets | $6.54B | $8.10B |
| Cash & Equivalents | $2.60B | $1.93B |
| Inventory | $153.0M | $117.0M |
| Total Liabilities | $3.69B | $3.24B |
| Current Liabilities | $1.99B | $2.21B |
| Long-term Debt | $590.0M | N/A |
| Total Debt | $590.0M† | N/A |
| Shareholders' Equity | $8.65B | $10.90B |
| Retained Earnings | $7.22B | $10.04B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$1.87B | -$3.00B |
| CapEx | $192.0M | $1.05B |
| Investing Cash Flow | $1.95B | $1.95B |
| Financing Cash Flow | $593.0M | $56.0M |
| Net Change in Cash | $668.0M | -$999.0M |
| Free Cash Flow | -$2.06B | -$4.05B |
FAQ
What is MRNA P/E and revenue?
Moderna Inc (MRNA) rev $1.94B.
What is MRNA revenue?
Moderna Inc last cached revenue is $1.94B (FY2025).
Is MRNA profitable?
Moderna Inc last cached net income is -$2.82B (FY2025).
What are MRNA total assets?
Moderna Inc last cached total assets are $12.34B (FY2025).
What is MRNA free cash flow?
Moderna Inc last cached free cash flow is -$2.06B (FY2025).
Not investment advice. Cached statements, not a live tape.